dc.contributor.author | Grasa, Eva | |
dc.contributor.author | Seppala, Jussi | |
dc.contributor.author | Alonso-Solis, Anna | |
dc.contributor.author | Haapea, Marianne | |
dc.contributor.author | Isohanni, Matti | |
dc.contributor.author | Miettunen, Jouko | |
dc.contributor.author | Mendivelso, Johanna Caro | |
dc.contributor.author | Almazan, Cari | |
dc.contributor.author | Rubinstein, Katya | |
dc.contributor.author | Caspi, Asaf | |
dc.contributor.author | Unoka, Zsolt | |
dc.contributor.author | Farkas, Kinga | |
dc.contributor.author | Usall, Judith | |
dc.contributor.author | Ochoa, Susana | |
dc.contributor.author | van der Graaf, Shenja | |
dc.contributor.author | Jewell, Charlotte | |
dc.contributor.author | Triantafillou, Anna | |
dc.contributor.author | Stevens, Matthias | |
dc.contributor.author | Reixach, Elisenda | |
dc.contributor.author | Berdun, Jesus | |
dc.contributor.author | m RESIST Grp, Iluminada | |
dc.contributor.author | Corripio, Iluminada | |
dc.date.accessioned | 2023-08-07T08:28:49Z | |
dc.date.available | 2023-07-30T17:28:52Z | |
dc.date.available | 2023-08-03T08:13:14Z | |
dc.date.available | 2023-08-07T08:28:49Z | |
dc.date.issued | 2023-06-30 | |
dc.identifier.issn | 2561-326X | |
dc.identifier.other | WOS:001029181800006 | |
dc.identifier.uri | https://imec-publications.be/handle/20.500.12860/42248.3 | |
dc.source | WOS | |
dc.title | m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study | |
dc.type | Journal article | |
dc.date.embargo | 9999-12-31 | |
dc.identifier.doi | 10.2196/46179 | |
dc.source.numberofpages | 13 | |
dc.source.peerreview | yes | |
dc.subject.discipline | Psychiatry & neurology | |
dc.source.beginpage | e46179 | |
dc.source.endpage | na | |
dc.source.journal | JMIR FORMATIVE RESEARCH | |
dc.identifier.pmid | MEDLINE:37389933 | |
dc.source.issue | / | |
dc.source.volume | 7 | |
imec.availability | Published - open access | |
dc.description.wosFundingText | Acknowledgments This work has been supported by the Horizon 2020 Framework Programme of the European Union (grant 643552) and partly funded by CERCA (Centres de Recerca de Catalunya) Programme/Generalitat de Catalunya. We thank all the patients whoparticipated in this study for their essential contribution to our field of research. We are also thankful to Ona Corporation (IIBSP-AMA2016-99) . | |